Versigent (VGNT) Stock Price
Versigent Price
Revenue has compounded at 3.2% per year over the past 3 years to 8.82 B USD. Earnings per share have grown at 5.2% per year over the last 3 years. Versigent's net margin stands at 6.0%, broadly stable from 5.7% several years earlier. Analysts set a median price target of 54.00 USD, implying 22.3% above the current price. Of 18 analysts, 16 rate the stock a buy — an overall Buy consensus.
Versigent stock price
Versigent business model & stock analysis
Frequently asked questions about Versigent
Analysts currently set an average price target of 53.44 USD for the Versigent stock (median: 54.00 USD), implying +21.1 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the Versigent stock: 16 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Versigent to generate revenue of 9.51 B USD and earnings per share of 7.32 USD.
Converted at the current exchange rate, the Versigent share trades at 39.39 EUR (44.14 USD).
The expected revenue of Versigent is 9.51 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Versigent is 520.09 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Versigent is currently 6.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Versigent stock.
The price-to-sales ratio (P/S) of Versigent is currently 0.33. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Versigent stock.
The Eulerpool Quality Score for Versigent is 4/10.
The ISIN of Versigent is JE00BWK75100. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Versigent is VGNT. The ticker symbol is used to trade Versigent shares on the stock exchange.
Versigent stock
Versigent Peer Group
All fundamentals and in-depth analysis of Versigent
Our stock analysis for Versigent stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Versigent. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.